ATE144536T1 - Cyclosporin- derivate - Google Patents

Cyclosporin- derivate

Info

Publication number: ATE144536T1
Authority: AT; Austria
Prior art keywords: cyclosporine derivatives; ser; ciclosporin; derivatives; cyclosporine
Prior art date: 1989-07-24

Application number

AT90810567T

Other languages

English (en)

Inventor

Marcel Karl Eberle

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-07-24

Filing date

1990-07-23

Publication date

1996-11-15

1990-07-23 Application filed by Sandoz Ag filed Critical Sandoz Ag

1996-11-15 Application granted granted Critical

1996-11-15 Publication of ATE144536T1 publication Critical patent/ATE144536T1/de

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical class CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title 1
208000023275 Autoimmune disease Diseases 0.000 abstract 1
206010052779 Transplant rejections Diseases 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
229960003444 immunosuppressant agent Drugs 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Birds (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT90810567T 1989-07-24 1990-07-23 Cyclosporin- derivate ATE144536T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898916901A GB8916901D0 (en)	1989-07-24	1989-07-24	Improvements in or relating to organic compounds

Publications (1)

Publication Number	Publication Date
ATE144536T1 true ATE144536T1 (de)	1996-11-15

Family

ID=10660543

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90810567T ATE144536T1 (de)	1989-07-24	1990-07-23	Cyclosporin- derivate

Country Status (22)

Country	Link
EP (1)	EP0414632B1 (de)
JP (1)	JPH0730113B2 (de)
KR (1)	KR100201174B1 (de)
AT (1)	ATE144536T1 (de)
AU (1)	AU631667B2 (de)
CA (1)	CA2021788C (de)
CZ (1)	CZ411691A3 (de)
DE (1)	DE69028967T2 (de)
DK (1)	DK0414632T3 (de)
ES (1)	ES2092500T3 (de)
FI (1)	FI94355C (de)
GB (1)	GB8916901D0 (de)
GR (1)	GR3021667T3 (de)
HU (1)	HU206127B (de)
IE (1)	IE902669A1 (de)
IL (1)	IL95154A (de)
MY (1)	MY105942A (de)
NZ (1)	NZ234613A (de)
PT (1)	PT94790B (de)
SA (1)	SA91110205B1 (de)
SK (1)	SK411691A3 (de)
ZA (1)	ZA905823B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9105705D0 (en) *	1991-03-18	1991-05-01	Sandoz Ltd	Improvements in or relating to organic compounds
GB9204466D0 (en) *	1992-03-02	1992-04-15	Sandoz Ltd	Improvements in or relating to organic compounds
US5482850A (en) *	1993-10-29	1996-01-09	New England Biolabs, Inc.	Method for identifying anti-parasitic compounds
WO1997011092A1 (en) *	1994-04-07	1997-03-27	Nippon Shinyaku Co., Ltd.	Cyclosporin phosphate derivatives and medicinal composition
US20030220234A1 (en)	1998-11-02	2003-11-27	Selvaraj Naicker	Deuterated cyclosporine analogs and their use as immunodulating agents
US20070032853A1 (en)	2002-03-27	2007-02-08	Hossainy Syed F	40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6790228B2 (en)	1999-12-23	2004-09-14	Advanced Cardiovascular Systems, Inc.	Coating for implantable devices and a method of forming the same
US7807211B2 (en)	1999-09-03	2010-10-05	Advanced Cardiovascular Systems, Inc.	Thermal treatment of an implantable medical device
KR100681670B1 (ko) *	2001-02-14	2007-02-09	주식회사 엘지생활건강	[감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
KR100465012B1 (ko)	2001-05-11	2005-01-13	주식회사 엘지생활건강	모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
WO2003033526A2 (en)	2001-10-19	2003-04-24	Isotechnika Inc.	Synthesis of cyclosporin analogs
KR100865211B1 (ko) *	2001-10-26	2008-10-23	주식회사 엘지생활건강	비면역 [감마 히드록시 엔-메틸 엘-루신4] 사이클로스포린 유도체를 유효성분으로 하는 항암 화학요법 기인 탈모증상 억제제
US6987090B2 (en)	2002-05-09	2006-01-17	Lg Household & Health Care Ltd.	Use of 3-position cyclosporin derivatives for hair growth
KR100439467B1 (ko) *	2002-11-13	2004-07-09	주식회사 엘지생활건강	모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US20050118344A1 (en)	2003-12-01	2005-06-02	Pacetti Stephen D.	Temperature controlled crimping
FR2873585B1 (fr) *	2004-07-27	2006-11-17	Aventis Pharma Sa	Nouvelles formulations galeniques de principes actifs
US7576057B2 (en)	2006-11-20	2009-08-18	Scynexis, Inc.	Cyclic peptides
CA2856034C (en) *	2011-11-15	2017-12-12	Allergan, Inc.	Cyclosporin a form 2 and method of making same
WO2020037530A1 (en)	2018-08-22	2020-02-27	Waterstone Pharmaceuticals (Wuhan) Co., Ltd.	Crystalline form of compound and uses thereof in medicine
CN118184532A (zh) *	2018-12-12	2024-06-14	中外制药株式会社	具有能形成分子内氢键的官能团的氨基酸、包含该氨基酸的肽化合物、及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH614931A5 (de)	1975-11-04	1979-12-28	Sandoz Ag
DE2819094A1 (de)	1977-05-10	1978-11-23	Sandoz Ag	Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv)	1978-10-18	1987-02-16	Sandoz Ag	Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
EP0034567B1 (de)	1980-02-14	1984-11-07	Sandoz Ag	Verfahren zur Totalsynthese von Cyclosporinen und neue Cyclosporine
US4396542A (en)	1980-02-14	1983-08-02	Sandoz Ltd.	Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
DE3260468D1 (en)	1981-01-09	1984-09-06	Sandoz Ag	Novel cyclosporins
CH667274A5 (de)	1984-03-23	1988-09-30	Sandoz Ag	Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
CY1915A (en)	1984-10-04	1985-09-27	Sandoz Ag	Cyclosporins
US4798823A (en)	1987-06-03	1989-01-17	Merck & Co., Inc.	New cyclosporin analogs with modified "C-9 amino acids"
ES2059558T3 (es) *	1987-06-17	1994-11-16	Sandoz Ag	Ciclosporins y su uso como productos farmaceuticos.
GB2206119B (en)	1987-06-22	1990-10-31	Merck & Co Inc	A new cyclosporin derivative with modified "8-amino acid"
GB8717300D0 (en)	1987-07-22	1987-08-26	Nat Res Dev	Cyclosporins
GB8717299D0 (en)	1987-07-22	1987-08-26	Nat Res Dev	Peptides
GB2207678A (en)	1987-08-03	1989-02-08	Merck & Co Inc	Novel immunosuppressive fluorinated cyclosporin analogs
HU205010B (en)	1987-09-15	1992-03-30	Sandoz Ag	Process for producing pharmaceutical compositions comprising compounds soluble up to 1 per cent and having medical activity
KR0148748B1 (ko)	1988-09-16	1998-08-17	장 크라메르, 한스 루돌프 하우스	사이클로스포린을 함유하는 약학조성물

1989
- 1989-07-24 GB GB898916901A patent/GB8916901D0/en active Pending
1990
- 1990-07-16 HU HU904224A patent/HU206127B/hu not_active IP Right Cessation
- 1990-07-20 MY MYPI90001215A patent/MY105942A/en unknown
- 1990-07-23 JP JP2197581A patent/JPH0730113B2/ja not_active Expired - Fee Related
- 1990-07-23 NZ NZ234613A patent/NZ234613A/en unknown
- 1990-07-23 AT AT90810567T patent/ATE144536T1/de not_active IP Right Cessation
- 1990-07-23 IL IL9515490A patent/IL95154A/en not_active IP Right Cessation
- 1990-07-23 PT PT94790A patent/PT94790B/pt not_active IP Right Cessation
- 1990-07-23 DK DK90810567.9T patent/DK0414632T3/da active
- 1990-07-23 IE IE266990A patent/IE902669A1/en not_active IP Right Cessation
- 1990-07-23 DE DE69028967T patent/DE69028967T2/de not_active Expired - Fee Related
- 1990-07-23 CA CA002021788A patent/CA2021788C/en not_active Expired - Fee Related
- 1990-07-23 EP EP90810567A patent/EP0414632B1/de not_active Expired - Lifetime
- 1990-07-23 KR KR1019900011144A patent/KR100201174B1/ko not_active Expired - Fee Related
- 1990-07-23 FI FI903706A patent/FI94355C/fi not_active IP Right Cessation
- 1990-07-23 AU AU59727/90A patent/AU631667B2/en not_active Ceased
- 1990-07-23 ES ES90810567T patent/ES2092500T3/es not_active Expired - Lifetime
- 1990-07-24 ZA ZA905823A patent/ZA905823B/xx unknown
1991
- 1991-01-05 SA SA91110205A patent/SA91110205B1/ar unknown
- 1991-12-27 CZ CS914116A patent/CZ411691A3/cs unknown
- 1991-12-27 SK SK4116-91A patent/SK411691A3/sk unknown
1996
- 1996-11-14 GR GR960403041T patent/GR3021667T3/el unknown

Also Published As

Publication number	Publication date
ES2092500T3 (es)	1996-12-01
MY105942A (en)	1995-02-28
HK1004268A1 (en)	1998-11-20
SA91110205B1 (ar)	2004-08-07
IL95154A (en)	1995-03-30
GR3021667T3 (en)	1997-02-28
FI94355C (fi)	1995-08-25
HUT54714A (en)	1991-03-28
HU904224D0 (en)	1990-12-28
ZA905823B (en)	1992-03-25
AU631667B2 (en)	1992-12-03
CA2021788C (en)	2001-02-13
JPH03218396A (ja)	1991-09-25
HU206127B (en)	1992-08-28
GB8916901D0 (en)	1989-09-06
FI94355B (fi)	1995-05-15
KR910002902A (ko)	1991-02-26
PT94790A (pt)	1991-03-20
EP0414632A3 (en)	1991-09-11
CA2021788A1 (en)	1991-01-25
JPH0730113B2 (ja)	1995-04-05
AU5972790A (en)	1991-01-24
EP0414632B1 (de)	1996-10-23
IL95154A0 (en)	1991-06-10
NZ234613A (en)	1992-09-25
FI903706A0 (fi)	1990-07-23
SK411691A3 (en)	1995-07-11
DE69028967T2 (de)	1997-05-15
CZ411691A3 (cs)	1998-06-17
IE902669A1 (en)	1991-02-27
KR100201174B1 (ko)	1999-06-15
PT94790B (pt)	1997-04-30
DE69028967D1 (de)	1996-11-28
EP0414632A2 (de)	1991-02-27
DK0414632T3 (da)	1996-11-25

Legal Events

Date	Code	Title
1997-05-15	UEP	Publication of translation of european patent specification
1997-06-15	EEFA	Change of the company name
2006-04-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DK0414632T3 (da)	1996-11-25	Cyclosporinderivater
MX9101869A (es)	1993-04-01	Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
CA2000786A1 (en)	1990-05-07	3-piperidinyl-1,2-benzisoxazoles
HU900846D0 (en)	1990-04-28	Process for preparation of substituted pyrroles
CA2172513A1 (en)	1995-03-30	Aminocyclohexylesters and uses thereof
HU9400686D0 (en)	1994-06-28	O-heteroaryl, o-alkyl-heteroaryl, o-alkenyl-heteroaryl and o-alkynyl-heteroary-macrolides
DE3886986D1 (de)	1994-02-24	Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
FR2670669B1 (fr)	1993-03-12	Instrument de correction chirurgicale de l'astigmatisme.
AU7370491A (en)	1991-10-03	2,8-dioxabicyclo(3,2,1)octane derivatives,their production from cultures of MF 5447 and MF 5466 and their use as anti hyper cholesterolemics
DE69113340D1 (de)	1995-11-02	Gekühlte, feuerfeste Körper und Verfahren zu ihrer Herstellung.
DE3769691D1 (de)	1991-06-06	Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
CA2071907A1 (en)	1991-06-21	Bcrf1 proteins as inhibitors of interferon-y
FI945854L (fi)	1994-12-13	6,7-dihydro-3-(2-nitrofenyyli)bentsisoksatsol-4(5H)-oneja ja menetelmä niiden valmistamiseksi
HU9201468D0 (en)	1992-07-28	Reduced rapamycin derivatives and medical preparations containing them
NO903338L (no)	1991-01-29	Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
EP0317913A3 (en)	1990-06-06	Di(meth)acrylates, process for their preparation and their use
DE59105948D1 (de)	1995-08-17	2-Amino-(fluoralkoxy-pyrimidine) und Verfahren zu ihrer Herstellung.
ATE111903T1 (de)	1994-10-15	Substituierte 1.2.3.4-oxatriazolium-5-olate, verfahren zu ihrer herstellung und ihre verwendung.
WO1990010006A3 (de)	1990-11-01	NEUE β-METHOXYACRYLATE, IHRE HERSTELLUNG UND VERWENDUNG
EP0317749A3 (de)	1989-08-16	Substituierte Benzimidazole und Benzothiadiazole
DE3886101D1 (de)	1994-01-20	14-Chlorodaunomycin und Verfahren zur Herstellung von 14-Chlorodaunomycin und Verfahren zur Herstellung von (2"R)-4'-O-Tetrahydropyramyladriamycin.
AU7463487A (en)	1988-01-07	3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3- heteroaryl-(thio) ureas
DE69116425D1 (de)	1996-02-29	Supraleitende Keramik und Verfahren zu ihrer Herstellung
CA2003794A1 (en)	1990-06-01	Expression of hiv proteins in drosophila cells
FR2698874B1 (fr)	1995-01-06	Procédé de préparation de dérivés d'acétoamides, d'acétothioamides et d'acétosélénoamides, en particulier de dérivés de carbamoylméthylphosphines et carbamoylméthylphosphines ainsi obtenues.